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Abstract. Tumour progression has been described as a sequence of traits or phenotypes 
that cells have to acquire if the neoplasm is to become an invasive and malignant cancer. 
Although the genetic mutations that lead to these phenotypes are random, the process by 
which some of these mutations become successful and spread is influenced by the tumour 
microenvironment and the presence of other phenotypes. It is thus likely that some 
phenotypes that are essential in tumour progression will emerge in the tumour population 
only with the prior presence of other different phenotypes. In this paper we use 
evolutionary game theory to analyse the interactions between three different tumour cell 
phenotypes defined by autonomous growth, anaerobic glycolysis, and cancer cell 
invasion. The model allows to understand certain specific aspects of glioma progression 
such as the emergence of diffuse tumour cell invasion in low-grade tumours. We find that 
the invasive phenotype is more likely to evolve after the appearance of the glycolytic 
phenotype which would explain the ubiquitous presence of invasive growth in malignant 
tumours. The result suggests that therapies which increase the fitness cost of switching to 
anaerobic glycolysis might decrease the probability of the emergence of more invasive 
phenotypes. 
 
Introduction 
 
Cancer cells display characteristic traits acquired in a step-wise manner during 
carcinogenesis. Some of these traits are autonomous growth, induction of neo-
angiogenesis, and invasion and metastasis (Hanahan and Weinberg, 2000).  Further 
characteristics of cancer cells include an altered glucose metabolism:  tumour cells 
commonly switch to glycolysis for energy production (Warburg, 1930).  FDG-PET (fluoro-
D-deoxyglucose positron emission tomography) and MRS (magnetic resonance 
spectroscopy) imaging allows for an in-vivo analysis of glucose metabolism and lactate 
concentrations. The clinical use of PET imaging and MRS has largely confirmed the 
ubiquitous switch to glycolysis in many cancers including malignant gliomas (Herholz et 
al., 1992; Padma et al., 2003; McKnight, 2004). Glycolysis is less efficient than the citrate 
cycle in terms of energy, but allows for survival in hypoxic environments, i.e. when oxygen 
demands by the growing number of tumour cells are no longer met by the vascular supply 
of the tumour. In addition, cells with a glycolytic metabolism can change the pH of the local 
microenvironment to their advantage. Cells with a non-glycolytic metabolism will often 
undergo apoptosis or necrosis after prolonged exposition to acidic conditions. It has been 
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suggested that tumour cells with a glycolytic metabolism evolve because of this fitness 
advantage over other cells (Gatenby et al., 2006).  
 
The prevalence of glycolysis in invasive tumours suggests that its presence could help the 
emergence of invasive phenotypes. Mathematical tools such as Game Theory (GT) can be 
used to study how the interplay between different phenotypes affects the outcome of 
tumour progression. GT models, first formalised by von Neumann and Morgernstern (von 
Neumann and Morgernstern, 1953), have a comparatively long tradition in the social and 
economic sciences. GT has also been successfully applied to the study of the evolutionary 
dynamics in nature (Nowak, 2006). More recently, GT has emerged as a tool in theoretical 
medicine. GT studies the interactions between entities called players where the fitness of 
each player depends on what the player decides to do (its strategy) as well as what the 
other players do. The players will obtain a fitness payoff as a result of these interactions. 
Maynard Smith (Maynard Smith, 1982) helped to establish evolutionary GT (EGT) as a tool 
for the study of equilibria in ecosystems. In EGT the strategies of the players, i.e. their 
phenotypes, are not the result of rational analysis but rather a behavior shaped through 
natural selection.  
 
In this paper we introduce a EGT model in which we explore the hypothesis put forward by 
Gatenby and colleagues (Gatenby et al., 2006) that glycolysis precedes tumour invasion 
and place the results in the context of gliomas, tumours of the central nervous system 
derived from glial cells. We have previously used a cellular automaton model to describe 
the growth of gliomas (Hatzikirou et al., 2005; Hatzikirou and Deutsch, 2007). The model 
did not include any provisions for the various glioma malignancy grades and malignant 
progression. In contrast, the present paper specifically focuses on these latter aspects of 
cancer biology. We start at a stage in tumourigenesis with cells that no longer require 
external growth factors and ignore external growth inhibitory signals (autonomous growth). 
We postulate that additional genetic mutations will either result in an invasive phenotype, 
or a switch to a glycolytic metabolism. The results show that a motile/invasive phenotype is 
more likely to evolve with the presence of glycolytic cells. 
 
Materials and methods 
 
We assume that all tumour cells are initially characterised by autonomous growth (AG 
phenotype). Cells can switch to anaerobic glycolysis for energy production (GLY 
phenotype), or become increasingly motile and invasive (INV phenotype). We make no 
assumptions as to what genetic changes are necessary for mutations to occur. The fitness 
of a cell with a given phenotype depends on its interaction with other cells that may have a 
different phenotype. Interactions between phenotypes are described in table 1. The  
base payoff, 1, represents the maximum fitness for a tumour cell under ideal 
circumstances in which it has to share nutrients and space with no other cell. The table is 
parametrised using variables: k, n and c. Variable k represents the fitness cost incurred by 
the switch to the less efficient glycolytic metabolism (GLY), n represents both: the loss of 
fitness for a non-glycolytic cell to live in an acid environment as well as the fitness gain for 
a glycolytic cell that increases the acidity of the microenvironment. Finally, c is the cost of  
motility incurred by cells with the INV phenotype resulting from the reduced proliferation 
rate of motile/invasive cells (Giese et al., 1996).  
  
 
Table 1. Payoff table that represents the change in fitness of a tumour cell with a given phenotype 
interacting with another cell. The three phenotypes in the game are autonomous growth (AG), 
invasive (INV) and glycolytic (GLY). The base payoff in a given interaction is equal to 1 and the 
cost of moving to another location with respect to the base payoff is c. The fitness cost of acidity is 
n and k is the fitness cost of having a less efficient glycolytic metabolism. The table should be 
read following the columns, thus the fitness change for an invasive cell interacting with an 
autonomous growth would be 1 − c. 
 
 AG INV GLY 
AG 
 
1-c 
 
INV 1 
 
1-k 
GLY 
 
1-c 
 
 
 
 
 
Table 1 should be read following the columns. For instance, the fitness payoff for an AG 
cell interacting with another AG, E(AG, AG), is 1/2 since AG cells have to share the 
available resources. When an AG cell meets an INV then the INV cell will leave for another 
location, obtaining the base payoff minus the cost of motility 1 − c, whereas the AG cell 
gets access to all the available resources and thus the base payoff. When an AG cell 
meets a GLY cell they both have to share the available resources. Furthermore, the AG 
cell loses fitness due to the acidification of the environment. GLY cells never get the full 
base payoff since their metabolism is less efficient. 
 
Results 
 
We have adopted a standard EGT analysis to study the equilibria between the different 
phenotypes in two scenarios: (1) mutation(s) leading to invasive cells capable of motility in 
a tumour composed of autonomous growth cells (AG, INV) and (2) a tumour containing 
autonomous growth, motile and glycolytic cells (AG, INV, GLY).  
 
 
Scenario 1: AG and INV 
 
This scenario studies the situation in which a mutation can confer motility/invasiveness to 
tumour cells that already capable of autonomous growth i.e. the tumor is populated by AG 
cells, which can acquire the INV phenotype.  
 
A population of AG cells is immune to invasion from a mutant INV phenotype if the fitness 
of two AG cells interacting together is greater than that of a mutant INV cells interacting 
with an AG cell. Alternatively, if the fitness of an AG cell playing with a second one is the 
1
2
1
2 + n − k
1− c2
1
2 − n
1
2 − k
  
same than that of an INV cell playing an AG cell, then AG cell might still be an immune to 
invasion if the payoff of an AG cell playing an INV cell is greater than that of an INV  
cell playing another INV cell. The payoff table shows that as long as motility represents a 
non negligible cost then the only thing required by a population of AG cells to be immune 
to invasion by an INV phenotype is that the fitness payoff of two AG cells is greater or 
equal than the fitness payoff for an INV cell interacting with an AG cell. That is, the AG 
phenotype is an immune to invasion only if c ≥ 1/2 . In many cases a polymorphism of INV 
and AG phenotypes will result. In these cases the fitness of the INV phenotype should be 
the same as that of the AG phenotype. If p is the proportion of invasive(INV) cells in the 
tumour, AG refers to the autonomous growth phenotype and W(P) the fitness of 
phenotype P: 
 
 
 
 
 
   
Scenario 2: AG, GLY and INV 
 
Here we study a tumour in which all three phenotypes coexist. Assuming that p refers to 
the proportion of INV cells and pʼ to the proportion of AG cells, the fitness of each of the 
phenotypes can be calculated as: 
 
 
 
 
 
In equilibrium the fitness of the three phenotypes is the same. The values of p and pʼ can 
be deduced from these equations. From these equivalencies:  
 
 
 
 
Figure 1 shows that the proportion of INV cells in the tumour, p, changes when we alter 
the values of the cost of having the GLY phenotype (k) and the cost of a normal cell living 
next to a GLY cell (n). For low values of k and high values of n the INV cells displace the 
other phenotypes from the tumour. This means that conditions favouring anaerobic 
glycolysis also favour tumour invasion. One possible explanation for this phenomenon is 
that the presence of glycolytic cells that increase the acidity of the environment will 
indirectly and comparatively reduce the costs of motility. 
 
W (I ) =W (AG)→
W (INV ) = A(AG)→
pE(INV , INV ) + (1− p)E(INV ,AG) = pE(AG, INV ) + (1− p)E(AG,AG)→
p(1− c2) + (1− p)(1− c) = p + (1− p)
1
2→
p = 1− 2c1− c
W (INV ) = p c2 +1− c
W (AG) = p(12 + n) + p 'n(
1
2 − n)
W (GLY ) = 12 p + np '+ (
1
2 − k)
p = 1− kn
p ' = 2kn + k − ck − cn2n2
  
 
 
Fig. 1. Proportion of invasive cells in a tumour with three phenotypes (autonomous growth, 
invasive and glycolytic). k is the cost in terms of fitness of adopting the glycolytic metabolism 
whereas n is the fitness cost of a normal cell when staying with a glycolytic cell. 
 
 
Figure 2 shows how the proportion of AG cells in the tumour population changes for 
variables k and n under four different scenarios for the cost of motility c. The proportion of 
AG cells increases as the cost of having a glycolytic metabolism increases or as the costs 
of living in an acid environment decreases thus reducing the proportion of both INV and 
GlY cells in the tumour. Interestingly, as the cost of motility increases the proportion of AG  
cells shrinks: higher costs of motility lead to more glycolytic cells that reduce the fitness of 
autonomous growth cells. 
  
 
 
 
 
   (a)      (b) 
 
 
   (c)      (d) 
 
Fig. 2. The figures imply that a higher cost of motility leads towards tumours with a small proportion 
of AG cells. The figures (a), (b), (c) and (d) show the proportion of autonomous growth cells in a 
tumour in which the three phenotypes (autonomous growth, invasive and glycolitic) are possible. 
Each scenario is characterised by a different value of c, the cost of motility: (a) c = 0. (b) c = 1/4 (c) 
c = 1/2 (d) c = 3/4 . 
 
 
 
Discussion 
 
Mathematical and computational models have been used to study tumour morphology and 
growth (Moreira and Deutsch, 2002; Anderson et al., 2006; Sanga et al., 2007) and 
therapy (Abbott and Michor, 2006). EGT has long been used to study the evolution of 
species but has only recently been applied to the analysis of the evolutionary aspects of 
cancer. Tomlinson and Bodmer (Tomlinson, 1997; Tomlinson and Bodmer, 1997) were the 
first to apply GT in cancer research. Their models study several cancer related problems 
such as angiogenesis and evasion of apoptosis. Subsequent research by Bach and 
colleagues extended this idea to interactions between three players (Bach et al., 2001) as 
well as the effect of spatial dynamics (Bach et al., 2003) on their angiogenesis game. 
Gatenby and Vincent adopted a game theory approach influenced by population dynamics 
  
to study tumour-host interactions in colorectal carcinogenesis (Gatenby and Vincent, 
2003). More recently, Mansury and colleagues (Mansury et al., 2006) have employed a 
non-evolutionary GT approach to study how the interactions between proliferative  and 
migratory phenotypes in a tumour affect a number of features of tumour growth dynamics. 
 
To the best of our knowledge, ours is the first attempt to use evolutionary game theory to 
analyse the interplay of different tumor cell phenotypes with respect to tumor invasion. Our 
model makes certain predictions that can be compared to clinical observations. Virtually all 
gliomas including low-grade tumours display some degree of invasion. Tumour cell 
infiltration of several cerebral lobes is occasionally seen and our model provides a simple 
explanation for this observation, and the apparent difference to many other cancers. The 
model predicts that motile/invasive (INV) and autonomously growing cells (AG) will coexist 
as long as the fitness costs of motility are not too high when compared to the fitness 
increase obtained by moving to a new location. Glioma invasion in the brain is facilitated 
by the presence of white matter tracts that lower the costs of motility (Giese and Westphal, 
1996). Relatively higher costs of motility are incurred by epithelial cancer cells, which have 
to transgress a formal barrier (the basal membrane separating the epithelial layer from the 
surrounding tissues), when compared to glioma cells. Furthermore, an invasive glioma cell 
will arrive in a surrounding very similar to the location from which it originated,  
i.e. in brain tissue. In contrast, an epithelial cancer cell leaves the context of other 
epithelial cells in order to grow among soft tissue cells and intracellular matrix molecules 
which may mean further fitness costs. 
 
Malignant progression is common and more than 50% of low-grade tumours will eventually 
become malignant (Schmidt et al., 2003). In the model, the emergence of the glycolytic 
phenotype is the correlate of malignant progression. FDG-PET and SRS imaging has 
shown a close correlation between histological malignancy grades and anaerobic 
glycolysis in gliomas (Herholz et al.; 1992, Padma et al.; 2003, McKnight, 2004).  
 
The results show that in a tumour populated by glycolytic cells, which in this model 
correlate with malignancy, invasive cells have a better chance of success (figure 1). 
Circumstances that favour the glycolytic phenotype also promote the emergence of the 
invasive phenotype. The proportion of invasive cells does not depend on the costs of 
motility, if all three phenotypes (AG, GLY, INV) are analysed in combination. This may 
reflect one of the fundamental tenets of malignant tumour progression. Malignant 
(glycolytic) tumours will also invariably, regardless of the specifics of the costs incurred,  
display a highly invasive phenotype. Invasion is a prerequisite for metastasis and, in most 
cases, characterises malignant tumours. Gatenby and co-workers have suggested a direct 
link between the glycolytic phenotype and tumour invasion and have provided 
experimental evidence to support this hypothesis (Gatenby et al., 2006).  
 
Invasive growth is not as closely related to malignancy in gliomas. As pointed out above, in 
the absence of glycolytic cells, the costs of motility do influence the emergence of the 
invasive phenotype, possibly reflecting the very specific environment of the brain. Hence, 
the model provides an explanation for the frequently invasive growth of slowly growing 
(benign AG) low-grade gliomas. Invasive growth is usually not seen in most other cancers 
with the AG phenotype. Malignant glial tumours (glial tumors with a GLY phenotype) 
infiltrate the surrounding brain parenchyma, as predicted by the model. Importantly, 
glycolysis has been shown to support astrocytoma invasion in a tissue culture model 
(Beckner et al., 2005). 
  
 
A mathematical model is necessarily a simplification of the complex situation found in a 
real tumour. Nevertheless, mathematical models provide theoretical frameworks in which 
to study qualitatively and quantitatively tumour progression (Gatenby and Maini, 2003; 
Anderson et al., 2006). Probably the most significant omission in our model is the lack of 
spatial considerations. Our previous research (Basanta et al., 2008) shows that game 
theoretical models of tumour invasion can have a similar predictive power than spatial 
ones based on Cellular Automata. Another possible future enhancement of the model 
would include changes in the way in which the fitness payoffs are considered. At the 
moment the costs of motility, acidity and glycolysis are considered to be constant. A more 
realistic approach would be to express these costs in terms of functions that could cover 
facts such as the increase in the costs of motility as the tumour grows leaving less space 
in which to move. Such enhancement would undoubtedly enrich the model but also make 
the analysis more difficult. Further research may also include the use of a larger number of 
phenotypes in the model, which are defined by molecular genetic aberrations (or sets 
thereof ), in order to allow for predictions of other important milestones in carcinogenesis. 
 
Our model explains in mathematical terms specific aspects of glioma growth i.e. invasion 
already in slowly growing tumors, and puts them in a more general context. In addition, 
mathematical modelling of tumour progression may enhance our understanding of cancer 
and provide new insights. Our findings suggest that strategies such as improving tissue 
oxygenation which increase the relative fitness costs of switching to anaerobic glycolysis 
may prevent invasion and metastasis.  
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